Cargando…

Production of Proteins of the SARS-CoV-2 Proteome for Drug Discovery

[Image: see text] The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative agent of the coronavirus disease of 2019 (COVID-19). Its genome encodes two open reading frames for two large proteins, PP1a and PP1ab. Within the two polypeptide stretches, there are two proteases th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Choon, Mahasenan, Kiran V., Bhardwaj, Atul, Wiest, Olaf, Chang, Mayland, Mobashery, Shahriar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315141/ https://www.ncbi.nlm.nih.gov/pubmed/34337272 http://dx.doi.org/10.1021/acsomega.1c02984

Ejemplares similares

Integrative structural biology of the penicillin-binding protein-1 from Staphylococcus aureus, an essential component of the divisome machinery
por: Martínez-Caballero, Siseth, et al.
Publicado: (2021)

Susceptibility of Methicillin-Resistant Staphylococcus aureus to Five Quinazolinone Antibacterials
por: Ceballos, Sara, et al.
Publicado: (2019)

SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
por: Liu, Xiaonan, et al.
Publicado: (2021)

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
por: Bhardwaj, Taniya, et al.
Publicado: (2023)

Glycosylation at Asn(211) Regulates the Activation State of the Discoidin Domain Receptor 1 (DDR1)
por: Fu, Hsueh-Liang, et al.
Publicado: (2014)

Drug Discovery Strategies for SARS-CoV-2
por: Shyr, Zeenat A., et al.
Publicado: (2020)

Mechanism of the Escherichia coli MltE lytic transglycosylase, the cell-wall-penetrating enzyme for Type VI secretion system assembly
por: Byun, Byungjin, et al.
Publicado: (2018)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2
por: Ebob, Oyere Tanyi, et al.
Publicado: (2021)

Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2
por: Prathiviraj, R., et al.
Publicado: (2020)

Drug discovery targeting SARS-CoV-2 membrane fusion
por: Yang, Kailu, et al.
Publicado: (2023)

Discovery of a Natural Product with Potent Efficacy Against SARS-CoV-2 by Drug Screening
por: Li, Daixi, et al.
Publicado: (2021)

Latin American databases of natural products: biodiversity and drug discovery against SARS-CoV-2
por: Núñez, Marvin J., et al.
Publicado: (2021)

Structure-based inhibitor design for reshaping bacterial morphology
por: Choi, Yuri, et al.
Publicado: (2022)

Déjà vu: Stimulating open drug discovery for SARS-CoV-2
por: Ekins, Sean, et al.
Publicado: (2020)

Drug discovery and development targeting the life cycle of SARS-CoV-2
por: Su, Haixia, et al.
Publicado: (2021)

MMP-9 inhibitors impair learning in spontaneously hypertensive rats
por: Raz, Limor, et al.
Publicado: (2018)

The zinc proteome of SARS-CoV-2
por: Andreini, Claudia, et al.
Publicado: (2022)

Discovery of Synergistic and Antagonistic Drug Combinations against SARS-CoV-2 In Vitro
por: Bobrowski, Tesia, et al.
Publicado: (2020)

Discovery of SARS-CoV-2 Antivirals through Large-scale Drug Repositioning
por: Riva, Laura, et al.
Publicado: (2020)

Structural basis of denuded glycan recognition by SPOR domains in bacterial cell division
por: Alcorlo, Martín, et al.
Publicado: (2019)

Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics
por: Pérez-Vargas, Jimena, et al.
Publicado: (2023)

Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery–Genetics Alliance Perspective
por: Pozzi, Cecilia, et al.
Publicado: (2023)

Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx
por: Vanderboom, Patrick M., et al.
Publicado: (2021)

Early Abrogation of Gelatinase Activity Extends the Time Window for tPA Thrombolysis after Embolic Focal Cerebral Ischemia in Mice
por: Chen, Shanyan, et al.
Publicado: (2018)

A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2
por: Singh, Rahul, et al.
Publicado: (2021)

Identification of genotypic variants and its proteomic mutations of Brazilian SARS-CoV-2 isolates
por: Prathiviraj, Ragothaman, et al.
Publicado: (2022)

Bioinformatical study on the proteomics and evolution of SARS-CoV
por: Liu, Shuqun, et al.
Publicado: (2003)

Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery
por: Chellapandi, P., et al.
Publicado: (2020)

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
por: Wu, Canrong, et al.
Publicado: (2020)

SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development
por: Murgolo, Nicholas, et al.
Publicado: (2021)

Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells
por: Pickard, Adam, et al.
Publicado: (2021)

The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2022)

Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery
por: Wang, Zhonglei, et al.
Publicado: (2021)

Potential Pathogenicity Determinants Identified from Structural Proteomics of SARS-CoV and SARS-CoV-2
por: Prates, Erica T, et al.
Publicado: (2020)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Bioinformatics resources for SARS-CoV-2 discovery and surveillance
por: Hu, Tao, et al.
Publicado: (2021)

Effectiveness of Remdesivir in Comparison with Five Approved Antiviral Drugs for Inhibition of RdRp in Combat with SARS-CoV-2
por: Mahdian, Soodeh, et al.
Publicado: (2022)

Penetration through Outer Membrane and Efflux Potential in Pseudomonas aeruginosa of Bulgecin A as an Adjuvant to β-Lactam Antibiotics
por: Kim, Choon, et al.
Publicado: (2023)

SARS-CoV-2 Production, Purification Methods and UV Inactivation for Proteomics and Structural Studies
por: Plavec, Zlatka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mbnqq4kj7tg04fcaicraj5qild